A smarter playbook for specialty pharmaceutical launches
Overview
Launching specialty therapies requires more than a traditional supply chain approach. As manufacturers navigate evolving regulatory requirements, market access considerations, and operational complexity, launch planning must become more connected, flexible, and scalable.
In this on-demand webinar, experts from Cencora explore how an integrated third-party logistics model can help manufacturers prepare for commercialization, support operational readiness, and plan for expansion across the United States and Europe.
What you will learn
- Why traditional launch approaches may not fully support today’s specialty pharmaceutical products.
- How integrated third-party logistics strategies can help reduce operational complexity.
- What manufacturers should consider when planning for U.S. launch and future European expansion.
- How to align packaging, labeling, quality, distribution, and regulatory planning earlier in the process.
- What advanced therapies may require from a logistics and operating model perspective.
- How flexible launch planning can support growth across multiple markets.
Why watch
You will hear how experienced leaders think about commercialization strategy, operational readiness, and scalable supply chain design across markets.
Featured speakers
Moderator: Fiona Chisholm Associate Director, Infectious Diseases, GlobalData
GJ Van Der Hulst Vice President, Integrated Solutions and Commercialization, Cencora
Krystal Haynes Senior Director, International 3PL Business Development
David de Wit Director, Regional Specialty Solutions, Cencora
Key discussion topics
- Specialty pharmaceutical launch trends.
- U.S. and European commercialization considerations.
- Operating model design for emerging and growing biopharma companies.
- Cross-functional coordination across supply chain, quality, regulatory, and commercial teams.
- Logistics planning for complex and advanced therapies.
- Building a scalable path from launch to expansion.
